464 40 mg (Emend 40 mg)
Generic Name: aprepitant
Pill with imprint 464 40 mg is White & Yellow, Capsule-shape and has been identified as Emend 40 mg. It is supplied by Merck & Company Inc.
Emend is used in the treatment of nausea/vomiting, chemotherapy induced and belongs to the drug class NK1 receptor antagonists. There is no proven risk in humans during pregnancy. Emend 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 464 40 mg
Emend
- Generic Name
- aprepitant
- Imprint
- 464 40 mg
- Strength
- 40 mg
- Color
- White & Yellow
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- NK1 receptor antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Company Inc.
- Inactive Ingredients
-
sucrose,
microcrystalline cellulose,
sodium lauryl sulfate,
titanium dioxide,
silicon dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00006-0464 (Discontinued) | Merck |
| 52959-0748 | H.J. Harkins Company, Inc. (repackager) |
Related images for "464 40 mg"
More about Emend (aprepitant)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (13)
- Drug images
- Pricing & coupons
- Generic availability
- En español
- Drug class: NK1 receptor antagonists
Patient resources
- Drug Information
- Emend (Advanced Reading)
- Emend (Aprepitant Capsules)
- Emend (Aprepitant Oral Suspension)
- Other brands
- Cinvanti
Professional resources
Other formulations
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.